Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Daiichi Sankyo
Johnson and Johnson
Federal Trade Commission
Cantor Fitzgerald

Generated: November 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 012342

« Back to Dashboard
NDA 012342 describes PARNATE, which is a drug marketed by Concordia Pharms Inc and is included in one NDA. It is available from three suppliers. Additional details are available on the PARNATE profile page.

The generic ingredient in PARNATE is tranylcypromine sulfate. There are six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the tranylcypromine sulfate profile page.

Summary for 012342

Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details

Pharmacology for NDA: 012342

Mechanism of ActionMonoamine Oxidase Inhibitors

Medical Subject Heading (MeSH) Categories for 012342

Suppliers and Packaging for NDA: 012342

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
tranylcypromine sulfate
TABLET;ORAL 012342 NDA AUTHORIZED GENERIC Actavis Pharma, Inc. 0591-5590 0591-5590-01 100 TABLET, FILM COATED in 1 BOTTLE (0591-5590-01)
tranylcypromine sulfate
TABLET;ORAL 012342 NDA Concordia Pharmaceuticals Inc. 59212-447 59212-447-10 100 TABLET, FILM COATED in 1 BOTTLE (59212-447-10)

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 10MG BASE
Approval Date:Aug 16, 1985TE:ABRLD:Yes

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
US Department of Justice
Harvard Business School
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus